Houston, TX - June 17th 2025 - OmniScience, the AI company behind Vivo - the first agentic AI control tower for clinical trials - is proud to announce that CEO and Co-Founder Angela Holmes has been named AI Entrepreneur of the Year by Women in AI North America.

The Women in AI (WAI) Awards recognize exceptional leaders driving meaningful innovation across artificial intelligence. The AI Entrepreneur of the Year award honors a founder who has demonstrated transformative impact, clear business value, and a bold vision for the future of AI.

Holmes was selected from a competitive field of AI entrepreneurs spanning North America. The recognition reflects her leadership in building OmniScience into one of the most forward-thinking companies in clinical research AI, and for developing Vivo, the first AI-powered platform capable of reasoning over complex clinical trial data to accelerate trial decisions, reduce delays, and increase probability of success.

“It’s an incredible honor to be named AI Entrepreneur of the Year by Women in AI,” said Holmes. “At OmniScience, we believe AI is most powerful when it augments - not replaces - human judgment. The work we’re doing is deeply technical, but also deeply human. It’s about empowering clinical teams with the clarity and confidence to move faster, ask better questions, and ultimately bring more treatments to patients who are waiting.”

Holmes’ leadership has helped shape OmniScience into a trusted partner for biotech and pharmaceutical teams navigating the growing complexity of clinical development. Under her direction, the company has earned top recognition at the Whale Tank competition at Innovation Network Gathering and the CNS Summit 2024 Innovation Showcase, and joined premier programs including Google for AI Startups, the NVIDIA Inception Program, and Johnson & Johnson’s JLABS.

As the AI landscape continues to evolve, Holmes and OmniScience are helping life sciences teams adopt next-generation tools that drive both scientific impact and operational efficiency - turning AI from an abstract concept into a practical advantage in the race to bring treatments to patients.

For more information visit the official announcement from Women In AI here.